CdkL4 Polyclonal Antibody

Cell cycle progression is controlled in part by a family of cyclin proteins and cyclin dependent kinases (Cdks). Cdk proteins work in concert with the cyclins to phosphorylate key substrates involved in each phase of cell cycle progression. Another family of proteins, Cdk inhibitors, also plays a role in regulating the cell cycle by binding to cyclin-Cdk complexes and modulating their activity. Cdks are considered potential targets for anti-cancer therapy due to their involvement with cell cycle regulation. Cdks are also involved in the regulation of transcription and mRNA processing. CdkL4 (cyclin-dependent kinase-like 4) is a 315 amino acid protein that belongs to the CMGC Ser/Thr protein kinase family and may be involved in cell cycle regulation.

The CdkL4 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of CdkL4 protein expression in various biological samples. This antibody has been meticulously developed using advanced immunization techniques, ensuring its exceptional sensitivity and specificity.

CdkL4, also known as Cyclin-dependent kinase-like 4, is a crucial regulator of cell cycle progression and plays a pivotal role in cellular proliferation and differentiation. Its aberrant expression has been implicated in numerous pathological conditions, including cancer and neurodegenerative disorders. Therefore, the accurate detection and quantification of CdkL4 protein levels are of utmost importance in both basic research and clinical applications.

The CdkL4 Polyclonal Antibody exhibits outstanding performance in various experimental techniques, including Western blotting, immunohistochemistry, and immunofluorescence. It recognizes endogenous levels of CdkL4 protein with high specificity, displaying minimal cross-reactivity with other related proteins. This antibody's exceptional sensitivity allows for the detection of even low-abundance CdkL4 protein, enabling precise and reliable quantification.

Furthermore, the CdkL4 Polyclonal Antibody has been rigorously validated using a wide range of sample types, including cell lysates, tissue extracts, and cultured cells. Its consistent and reproducible results make it an ideal choice for researchers and clinicians alike.

In summary, the CdkL4 Polyclonal Antibody is a top-tier research tool that offers exceptional sensitivity, specificity, and reliability for the detection and analysis of CdkL4 protein expression. Its robust performance in various experimental techniques, along with its extensive validation, makes it an invaluable asset in advancing our understanding of CdkL4's role in cellular processes and its potential implications in disease pathogenesis.